Velagliflozin, sold under the brand name Senvelgo, is an antidiabetic medication used for the treatment of cats.

[2][4] Velagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.

[2] Velagliflozin is indicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.

This veterinary medicine–related article is a stub.

You can help Wikipedia by expanding it.